CollPlant Biotechnologies (CLGN) Beginning Cash Balance (2019 - 2022)

CollPlant Biotechnologies' Beginning Cash Balance history runs 4 years deep, the most recent figure standing at $13.4 million for Q4 2022.

• Quarterly Beginning Cash Balance changed N/A year-over-year to $13.4 million in Q4 2022, while the trailing twelve-month figure through Sep 2025 was $13.4 million (down 50.0% YoY) and the FY2022 annual result came in at $13.4 million, up 279.3% from the prior year.
• Beginning Cash Balance was $13.4 million for Q4 2022 at CollPlant Biotechnologies, roughly flat from $13.4 million in the prior quarter.
• Across five years, Beginning Cash Balance topped out at $13.4 million in Q1 2022 and bottomed at $3.5 million in Q1 2021.
• A 4-year average of $8.0 million and a median of $5.7 million in 2019 frame the typical range for Beginning Cash Balance.
• Annual changes were most pronounced in 2020 — Beginning Cash Balance fell 29.88% — and 2022, when it jumped 279.3%.
• CollPlant Biotechnologies' Beginning Cash Balance stood at $5.7 million in 2019, then decreased by 29.88% to $4.0 million in 2020, then slipped by 11.21% to $3.5 million in 2021, then soared by 279.3% to $13.4 million in 2022.
• Business Quant data shows CLGN's Beginning Cash Balance at $13.4 million in Q4 2022, $13.4 million in Q1 2022, and $3.5 million in Q1 2021.